David Leverett

Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony‐stimulating factor (G‐CSF): impact of age, sex, donor weight and type of G‐CSF used

Stuart J. Ings, Carmen Balsa, David Leverett et al. · British Journal of Haematology · 2006 · 147 citations

Medicine, Cell Biology, Hematology +15

Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization.

Michael Watts, Angela Sullivan, David Leverett et al. · Journal of Clinical Oncology · 1998 · 63 citations

Medicine, Hematology, Cell Therapy +16

ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m−2 and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients

Michael Watts, Stuart J. Ings, David Leverett et al. · British Journal of Cancer · 2000 · 62 citations · Full text

Medicine, Hematology, Oncology +16

Evaluation of clinical scale CD34+ cell purification: experience of 71 immunoaffinity column procedures

MJ Watts, SJ Ings, David Leverett et al. · Bone Marrow Transplantation · 1997 · 32 citations

Pharmacy, Cell Biology, Hematology +10

Characterization of the complications associated with plasma exchange for thrombotic thrombocytopaenic purpura and related thrombotic microangiopathic anaemias: a single institution experience

Siobhan McGuckin, John Paul Westwood, Henry Goodwin Webster et al. · Vox Sanguinis · 2013 · 32 citations · Full text

Medicine, Hematology, Internal Medicine +17